Amneal Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AMRX for the last quarter is 616.98 M USD, and it's 0.49% lower compared to the previous quarter. The net income of Q4 23 is -98.65 M USD.